MRT Inc. (6034) AI Stock Analysis

• Market Cap: ¥3.91B
• Dividend Yield: N/A
• Average Volume (3M): 9.31K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.02
• Revenue Growth: -7.73%
• EPS Growth: -303.99%
• Country: JP
• Employees: 304
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -18.72
• Shares Outstanding: 5,718,600
• 10 Day Avg. Volume: 1,680
• 30 Day Avg. Volume: 9,313
• PEG Ratio: 0.02
• Price to Book (P/B): 2.08
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 2.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥750.00
• Price Target Upside: 6.99% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 50 Neutral
• Price Target: ¥701.00 ▲(0.00%Upside)

MRT Inc.'s financial performance is the primary concern, driven by negative profitability and declining asset base. Technical analysis indicates bearish momentum, with potential for price rebound due to oversold conditions. Valuation remains unattractive, influenced by negative earnings and lack of dividends. Improving financial stability and profitability are crucial for a positive outlook.

MRT Inc. Business Overview & Revenue Model

Company Description

MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling, and online medical care; Pocket Doctor, a telemedicine/health consultation app; groupware for medical offices; FASTCALL that consolidates the functions required for hospital crisis management system as safety confirmation service for medical institution; and Good Doctors, which provides owned media sent by doctors. It also offers nurse and pharmacist recruitment service; human resources introduction service for clinical laboratory engineers, radiologists, and dialysis nurses, as well as for new business openings and succession projects; and recruitment information service for exclusive industrial physicians and contract industrial physicians. In addition, the company engages in employment agency business, opening of business, business succession support business, and PR business, and career support business. Further, it offers services for supporting the operation of medical institutions, such as fund management, utilizing medical fee factoring, payroll calculation for doctors' part-time jobs, and payroll transfer agency services. Additionally, the company sells human umbilical cord-derived stem cell culture supernatant; and provides babysitter services, tax accountant referral service, credit card payment agency service, questionnaire survey request for pharmaceuticals, etc., as well as media coverage cooperation, lecture request, event rescue, etc. It also publishes books on illness and treatment; and offers health maintenance service and member comprehensive compensation systems. The company was formerly known as Medical Research and Technology Co., Ltd and changed its name to MRT Inc. in September 2014. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

How the Company Makes Money

MRT Inc. makes money primarily through the sale of its optical components and systems to businesses in the telecommunications and data center industries. Its revenue streams include direct sales to large corporations and original equipment manufacturers (OEMs), as well as through distribution partnerships with key players in the technology sector. The company benefits from long-term contracts with major clients, providing a stable and recurring revenue base. Strategic partnerships with leading technology firms also enhance its market reach and contribute significantly to its earnings. Additionally, MRT Inc. invests in research and development to continuously improve its product offerings, thereby maintaining a competitive edge in the rapidly evolving optical technology market.

MRT Inc. Financial Statement Overview

Summary

MRT Inc. faces significant challenges in its income statement with negative EBIT and net income, indicating operating losses. The balance sheet shows strength with a low debt-to-equity ratio, suggesting financial stability. Cash flow management is effective, with positive cash flow from operations, but the company faces risks from income volatility and a declining asset base.

Income Statement

MRT Inc. has faced significant challenges in its income statement over the recent periods. The TTM data shows negative EBIT and net income, indicating substantial operating losses. The gross profit margin remains relatively stable but is overshadowed by the declining revenue and profitability. The revenue has shown volatility, with a marked decrease from previous highs, and the net profit margin is negative, reflecting ongoing difficulties in achieving profit.

Balance Sheet

The balance sheet of MRT Inc. displays some positive aspects, such as a strong equity position and a low debt-to-equity ratio, indicating financial stability. The equity ratio is healthy, suggesting that the company has a solid asset base. However, the consistent decrease in total assets and stockholders' equity over recent periods could be cause for concern if the trend continues.

Cash Flow

Cash flow from operations is positive in TTM, reflecting some operational resilience despite challenges in profitability. The free cash flow has grown, indicating effective management of capital expenditures. However, the operating cash flow to net income ratio is skewed due to negative net income, and fluctuations in cash flow from financing and investing activities may impact future liquidity.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.23B	4.17B	5.41B	8.74B	4.47B	2.56B
Gross Profit	2.72B	2.74B	3.27B	5.60B	3.55B	1.76B
EBITDA	84.76M	139.00M	1.10B	3.16B	1.45B	420.18M
Net Income	-348.94M	-309.16M	517.00M	2.16B	774.49M	131.81M
Balance Sheet
Total Assets	6.10B	6.75B	6.47B	8.16B	4.98B	3.31B
Cash, Cash Equivalents and Short-Term Investments	1.85B	2.62B	3.78B	4.90B	1.03B	1.59B
Total Debt	693.48M	1.05B	641.00M	875.86M	1.04B	1.11B
Total Liabilities	1.69B	2.12B	1.76B	3.67B	2.69B	1.75B
Stockholders Equity	4.32B	4.52B	4.58B	4.39B	2.22B	1.52B
Cash Flow
Free Cash Flow	488.87M	462.00M	-208.00M	4.43B	-405.64M	183.97M
Operating Cash Flow	521.49M	503.04M	-193.00M	4.51B	-298.89M	294.97M
Investing Cash Flow	-1.92B	-1.84B	-243.61M	-431.11M	-206.51M	-64.61M
Financing Cash Flow	-136.99M	161.77M	-669.19M	-203.98M	-67.49M	-397.41M

MRT Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 701.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 701 is below the 20-day moving average (MA) of 723.60, below the 50-day MA of 722.86, and below the 200-day MA of 731.19, indicating a bearish trend. The MACD of -5.30 indicates Positive momentum. The RSI at 40.87 is Neutral, neither overbought nor oversold. The STOCH value of 35.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.

MRT Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3671	85 Outperform	¥7.82B	12.07		1364.13%	16.07%	72.83%
6545	72 Outperform	¥3.47B	13.49		1.86%	4.08%	94.18%
4438	53 Neutral	¥3.04B	―		―	-4.68%	-62.31%
Sector *	52 Neutral	$7.52B	0.25	-63.76%	2.30%	16.15%	0.89%
6034	50 Neutral	¥3.91B	―		―	-7.73%	-303.99%
3628	50 Neutral	¥7.73B	―		―	16.49%	-483.70%
3902	43 Neutral	¥16.38B	4,465.71		1.55%	-7.98%	-181.00%